Arden Anglican School wins SunSafe Ambassador competition
13 December 2018
Three students from Arden Anglican School in Epping have won Melanoma Institute Australia’s (MIA) inaugural SunSafe Student Ambassador Award for their engaging and inspiring presentation to their peers about how to be sun safe and help prevent melanoma.
Year 10 students Kaela (16), Oliver (16) and Kimberley (16) were nominated by their school to join other students at MIA’s one-day SunSafe Student Ambassador Program at The Poche Centre in Wollstonecraft, where they learned about melanoma and the importance of sun safety.
The program was also designed to assist students in developing their presentation skills, so they could create a personalised sun safe presentation to deliver at their school.
The students returned to their schools to deliver their own SunSafe presentation to their peers, with nine schools submitting videos of the student presentations for judging by MIA’s expert panel, including the Chair of MIA’s Education Committee Associate Professor Robyn Saw, Director of Speak Out Schools Kat Collins, and MIA CEO Matthew Browne.
The students from Arden Anglican School were announced as the winners and were today presented with their award at the final Year 10 Meeting for the year by Melanoma Institute Australia CEO Matthew Browne.
‘I thought the three Arden ambassadors were very engaging,’ said Mr. Browne.
‘Kaela, Oliver and Kimberley’s presentation would have undoubtedly convinced many of their peers to cover up and protect themselves from the sun, a critically important message particularly for teenagers.’
UV exposure leading to sunburn is the greatest risk factor for developing melanoma. One Australian dies every five hours from melanoma, which is also the most common cancer affecting 15 to 39 year old Australians.
MIA’s SunSafe Student Ambassador Program will be rolled out in six locations across east coast of Australia in late 2019. Schools interested in participating can fill out the expression of interest form here.
Two publications co-edited by MIA Co-Medical Director Professor Richard Scolyer are now available to healthcare professionals. They aim to provide assistance in the care and management of patients with skin cancer, including melanoma.
Melanoma Institute Australia has introduced a new educational program to teach teenagers about the dangers of melanoma and the importance of sun safety.
"International collaboration remains the key to ensuring this pioneering research continues so we can increase survival rates for advanced melanoma patients and move us closer to achieving our goal of zero deaths from melanoma," says Professor Georgina Long, of the clinical trial results presented at ESMO 2018.
Research that could change clinical practice for high-risk Stage III melanoma patients has been presented at the European Society for Medical Oncology (ESMO) Congress in Munich.
A larger, monthly dose of immunotherapy can give melanoma patients more freedom without sacrificing effectiveness.
The Australasian Melanoma Conference, hosted by the Australasian Melanoma Conference Committee, was held in Melbourne on the weekend, with many of MIA's clinicians in attendance.
The two men who discovered checkpoint inhibitors, the brakes of the immune system, were awarded the Nobel Prize in Physiology or Medicine on Monday, October 1.
The World Health Organisation (WHO) is releasing the 4th edition of Classification of Skin Tumours.
Former Executive Director of Melanoma Institute Australia Professor John Thompson awarded the prestigious 2018 RPA Foundation Research Medal.
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for pembrolizumab.
The World Congress on Cancers of the Skin 2018 has featured many minds from MIA sharing their expertise and wealth of knowledge with over 1000 attendees from around the world.
Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.
A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.